A Novel Third Generation Thiosemicarbazone, COTI-2, Is Highly Effective in Killing Head and Neck Squamous Cell Carcinomas (HNSCC) Bearing a Variety of TP53 Mutations
Year: 2016
Type: article
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2295334918
